Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity.
Leone C, Di Stefano G, Di Pietro G, Bloms-Funke P, Boesl I, Caspani O, Chapman SC, Finnerup NB, Garcia-Larrea L, Li T, Goetz M, Mouraux A, Pelz B, Pogatzki-Zahn E, Schilder A, Schnetter E, Schubart K, Tracey I, Troconiz IF, Van Niel H, Hernandez JMV, Vincent K, Vollert J, Wanigasekera V, Wittayer M, Phillips KG, Truini A, Treede RD. Leone C, et al. Among authors: phillips kg. Trials. 2022 Sep 5;23(1):739. doi: 10.1186/s13063-022-06431-5. Trials. 2022. PMID: 36064434 Free PMC article.
IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG).
Mouraux A, Bloms-Funke P, Boesl I, Caspani O, Chapman SC, Di Stefano G, Finnerup NB, Garcia-Larrea L, Goetz M, Kostenko A, Pelz B, Pogatzki-Zahn E, Schubart K, Stouffs A, Truini A, Tracey I, Troconiz IF, Van Niel J, Vela JM, Vincent K, Vollert J, Wanigasekera V, Wittayer M, Phillips KG, Treede RD. Mouraux A, et al. Among authors: phillips kg. Trials. 2021 Jun 17;22(1):404. doi: 10.1186/s13063-021-05272-y. Trials. 2021. PMID: 34140041 Free PMC article. Clinical Trial.
Modulation of the N13 component of the somatosensory evoked potentials in an experimental model of central sensitization in humans.
Di Lionardo A, Di Stefano G, Leone C, Di Pietro G, Sgro E, Malara E, Cosentino C, Mollica C, Blockeel AJ, Caspani O, Garcia-Larrea L, Mouraux A, Treede RD, Phillips KG, Valeriani M, Truini A. Di Lionardo A, et al. Among authors: phillips kg. Sci Rep. 2021 Oct 21;11(1):20838. doi: 10.1038/s41598-021-00313-7. Sci Rep. 2021. PMID: 34675309 Free PMC article.
The N13 spinal component of somatosensory evoked potentials is modulated by heterotopic noxious conditioning stimulation suggesting an involvement of spinal wide dynamic range neurons.
Pietro GD, Stefano GD, Leone C, Lionardo AD, Sgrò E, Blockeel AJ, Caspani O, Garcia-Larrea L, Mouraux A, Phillips KG, Treede RD, Valeriani M, Truini A. Pietro GD, et al. Among authors: phillips kg. Neurophysiol Clin. 2021 Dec;51(6):517-523. doi: 10.1016/j.neucli.2021.09.001. Epub 2021 Oct 28. Neurophysiol Clin. 2021. PMID: 34756635 Free article.
IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET).
Nochi Z, Pia H, Bloms-Funke P, Boesl I, Caspani O, Chapman SC, Fardo F, Genser B, Goetz M, Kostenko AV, Leone C, Li T, Mouraux A, Pelz B, Pogatzki-Zahn E, Schilder A, Schnetter E, Schubart K, Stouffs A, Tracey I, Troconiz IF, Truini A, Van Niel J, Vela JM, Vincent K, Vollert J, Wanigasekera V, Wittayer M, Tankisi H, Finnerup NB, Phillips KG, Treede RD. Nochi Z, et al. Among authors: phillips kg. Trials. 2022 Feb 19;23(1):163. doi: 10.1186/s13063-022-06087-1. Trials. 2022. PMID: 35183242 Free PMC article.
Pharmacological Probes to Validate Biomarkers for Analgesic Drug Development.
van Niel J, Bloms-Funke P, Caspani O, Cendros JM, Garcia-Larrea L, Truini A, Tracey I, Chapman SC, Marco-Ariño N, Troconiz IF, Phillips K, Finnerup NB, Mouraux A, Treede RD. van Niel J, et al. Int J Mol Sci. 2022 Jul 27;23(15):8295. doi: 10.3390/ijms23158295. Int J Mol Sci. 2022. PMID: 35955432 Free PMC article.
Erratum to 'The N13 spinal component of somatosensory evoked potentials is modulated by heterotopic noxious conditioning stimulation suggesting an involvement of spinal wide dynamic range neurons'.
Di Pietro G, Di Stefano G, Leone C, Di Lionardo A, Sgro E, Blockeel AJ, Caspani O, Garcia-Larrea L, Mouraux A, Phillips KG, Treede RD, Valeriani M, Truini A. Di Pietro G, et al. Among authors: phillips kg. Neurophysiol Clin. 2022 Oct;52(5):410-411. doi: 10.1016/j.neucli.2022.09.001. Epub 2022 Oct 6. Neurophysiol Clin. 2022. PMID: 36210258 No abstract available.
Erratum to "How different experimental models of secondary hyperalgesia change the nociceptive flexion reflex" [Clin. Neurophysiol. 132 (2021) 2989-2995].
Leone C, Di Lionardo A, Di Pietro G, Di Stefano G, Falco P, Blockeel AJ, Caspani O, Garcia-Larrea L, Mouraux A, Phillips KG, Treede RD, Truini A. Leone C, et al. Among authors: phillips kg. Clin Neurophysiol. 2023 Jan;145:162. doi: 10.1016/j.clinph.2022.07.499. Epub 2022 Nov 7. Clin Neurophysiol. 2023. PMID: 36357284 Free article. No abstract available.
84 results